Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - Yubo International Biotech Ltd | yubo_ex321.htm |
| EX-32.2 - CERTIFICATION - Yubo International Biotech Ltd | yubo_ex312.htm |
| EX-31.1 - CERTIFICATION - Yubo International Biotech Ltd | yubo_ex311.htm |
| EX-10.17 - SUPPLEMENT AGREEMENT - Yubo International Biotech Ltd | yubo_ex1017.htm |
| EX-10.16 - LEASE AGREEMENT - Yubo International Biotech Ltd | yubo_ex1016.htm |
| 10-Q - FORM 10-Q - Yubo International Biotech Ltd | yubo_10q.htm |
EXHIBIT 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
In connection with the accompanying quarterly report on Form 10-Q of Yubo International Biotech Limited for the quarter ended March 31, 2021, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
|
| (1) | such quarterly report on Form 10-Q for the quarter ended March 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
|
| (2) | the information contained in such quarterly report on Form 10-Q for the quarter ended March 31, 2021 fairly presents, in all material respects, the financial condition and results of operations of Yubo International Biotech Limited. |
| Date: May 24, 2021 | /s/ Lina Liu | ||
|
|
| Name: Lina Liu |
|
|
|
| Title: Chief Financial Officer |
|